Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Private sector & early diagnosis to help India tackle retinopathy among 32 million diabetics

This article was originally published in Clinica

Executive Summary

Early diagnosis of diabetic retinopathy in India and greater use of mobile units, is essential to reduce its prevalence. So said Dr Rengappa Ramakrishnan, chief medical officer of Aravind Eye Hospital (Tirunelvelli), in an interview with Clinica. Additionally, observers have suggested that more private clinics could help reduce incidence levels and the burden on public hospitals.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel